Blood plasma, fibrinogen, and fibrin have long been explored for their role in skin tissue engineering and dermatological ...

SolasCure has initiated a new Phase II clinical trial, CLEANVLU2, to further the development of its investigational product, ...

SOLASCURE Ltd (SolasCure), a biotechnology company developing a novel treatment to transform chronic wound healing, today ...

UK biotechnology company SolasCure has commenced the randomised, controlled CLEANVLU2 Phase II trial of Aurase Wound Gel for ...

Phase II clinical trial to determine the efficacy of Aurase Wound Gel at a higher concentration of the active enzyme Tarumase in venous leg ulcers SOLASCURE Ltd (SolasCure), a biotechnology company ...

Aurase Wound Gel is a hydrogel releasing Tarumase, a recombinant enzyme originally cloned from medical maggots that selectively targets fibrin, collagen and elastin in wounds to promote healing ...

Thrombin mediates fibrin polymerization and is known to be involved in acute and chronic inflammatory processes in vivo. Flick et al. have used various genetically engineered mouse models to study ...